Montelukast in allergic rhinitis: a systematic review and meta‐analysis

@article{Grainger2006MontelukastIA,
  title={Montelukast in allergic rhinitis: a systematic review and meta‐analysis},
  author={John R. Grainger and Adrian Drake-Lee},
  journal={Clinical Otolaryngology},
  year={2006},
  volume={31}
}
• Allergic rhinitis is common. 
Leukotriene receptor antagonist in the treatment of childhood allergic rhinitis—a randomized placebo‐controlled study
This study was designed to assess the hypothesis that leukotriene receptor antagonists (LTRAs) would provide additional symptom relief in asthmatic children with persistent AR already taking regularExpand
Montelukast in the treatment of asthma and allergic rhinitis
TLDR
An overview of the pharmacology of montelukast and the guidline recommendations for its use in asthma and allergic rhinitis is provided. Expand
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
  • S. Wise, Sandra Y. Lin, +69 authors M. Zacharek
  • Medicine
  • International forum of allergy & rhinology
  • 2018
TLDR
To evaluate the existing AR literature, international multidisciplinary experts with an interest in AR have produced the International Consensus statement on Allergy and Rhinology: Allergic Rhinitis (ICAR:AR). Expand
Pharmacotherapy of rhinitis and rhinosinusitis.
TLDR
The pharmacotherapy of allergic and nonallergic rhinoconjunctivitis and rhinosinusitis is discussed with emphasis on intranasal steroids, antihistamines, and antibiotics. Expand
The link between allergic rhinitis and asthma: a role for antileukotrienes?
TLDR
The present article reviews the shared components of allergic rhinitis and asthma, and examines recent evidence supporting antileukotrienes as effective agents in reducing the symptoms of both diseases. Expand
Intranasal Ciclesonide in Allergic Rhinitis
TLDR
Ciclesonide has shown so far a very good safety and pharmacokinetic profile and is effective for treatment of symptoms in both seasonal and perennial allergic rhinitis. Expand
Allergic Rhinitis: Mechanisms and Treatment.
TLDR
A comprehensive multiple modality treatment plan customized to the individual patient can optimize outcomes of allergic rhinitis. Expand
Role of Leukotriene Antagonists and Antihistamines in the Treatment of Allergic Rhinitis
TLDR
The published literature about combined antihistamines and leukotriene antagonists in mono- or combination therapy is reviewed and presented. Expand
Leukotriene receptor antagonists in allergic eye disease: a systematic review and meta-analysis.
TLDR
In seasonal AC LTRAs are more efficacious than placebo but less efficacity than oral antihistamines in adult patients, and clinical trials should be conducted to determine whether combination treatment with LTRA and oralAntihistamine has a synergistic effect. Expand
Update on Clinical Options for the Management of Allergic Rhinitis
TLDR
Treatment of allergic rhinitis includes identification of relevant allergens, education on avoidance measures, medications and immunotherapy, which is an effective treatment option for refractory disease. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 62 REFERENCES
Montelukast for treating seasonal allergic rhinitis: a randomized, double‐blind, placebo‐controlled trial performed in the spring
  • G. Philip, K. Malmstrom, +5 authors T. Reiss
  • Medicine
  • Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
  • 2002
Background Cysteinyl leukotrienes are important proinflammatory mediators believed to have a role in allergic rhinitis.
Montelukast improves symptoms of seasonal allergic rhinitis over a 4‐week treatment period
TLDR
The efficacy and tolerability of montelukast, a cysteinyl leukotriene receptor antagonist, given once daily in the morning for treatment of seasonal (fall) allergic rhinitis for 4 weeks is evaluated. Expand
A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma
TLDR
This work has shown that leukotriene antagonists may be an alternative to corticosteroid therapy in allergic rhinitis and asthma and may also be a viable alternative to chemotherapy. Expand
Effects of monotherapy with intra‐nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis
The combination of a leukotriene receptor antagonist with an antihistamine may have beneficial effects in seasonal allergic rhinitis (SAR).
An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma
TLDR
Nasal polyposis occurs frequently in patients with intrinsic asthma, especially in those who are aspirin sensitive, and even with surgery and regular topical intranasal corticosteroids many patients are still symptomatic. Expand
Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation
TLDR
Investigation of effects of 6‐week pretreatment of seasonal allergic rhinitis with cetirizine, and montelukast, alone and in combination found antihistamine/antileukotriene treatment is effective in AR. Expand
Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow
Measurement of domiciliary nasal peak inspiratory flow rate (PIFR) may have a role in the objective assessment of treatment response in seasonal allergic rhinitis (SAR).
Randomized placebo‐controlled trial comparing fluticasone aqueous nasal spray in mono‐therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis
  • G. Di Lorenzo, M. Pacor, +10 authors C. Caruso
  • Medicine
  • Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
  • 2004
Background Corticosteroids are considered to be particularly effective in reducing nasal congestion and are therefore recommended as first‐line treatment in allergic rhinitis patients with moderateExpand
The effect of leukotriene‐modifier drugs on aspirin‐induced asthma and rhinitis reactions
Background Leukotrienes (LTs) appear to be crucial mediators of aspirin (ASA)‐induced lower respiratory tract reactions. Therefore, it is logical to assume that leukotriene‐modifier drugs (LTMDs)Expand
Burden of allergic disease in the UK: secondary analyses of national databases
TLDR
This work states that there is little reliable information on the overall disease burden posed by allergic conditions in the UK and recommends that patients be screened for these conditions before, during and after hospital treatment. Expand
...
1
2
3
4
5
...